Cite
HARVARD Citation
Kantarjian, H. et al. (n.d.). Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial. Lancet oncology. 18 (10), pp. 1317-1326. [Online].